Check out your Company Bowl for anonymous work chats.
In honor of Earth Day this past Saturday, we’re shedding light on our commitment to bettering the climate. At Syneos Health, we’re devoted to advancing health, caring for people, operating responsibly, and protecting the planet. Learn more about joining us and our dedication to sustainability, which will ultimately help advance health and change patients’ lives: http://ow.ly/MEZR50NRyyP
Our #SyneosHealth Consulting team answers which Go to Market strategies lead to the greatest commercial success in cell therapies and more in a new whitepaper. Explore market trends and how choosing the right GTM strategy can impact the trajectory of commercial success, https://lnkd.in/eKwHMfuS
Syneos Health collaborates with Microsoft to utilize Microsoft Azure services in developing an advanced analytics platform supporting the analysis, design and execution of clinical trials and commercial programs worldwide. Learn more: https://lnkd.in/geNp6kaw #SyneosHealth #AI
Congratulations to the 2022 Year End Award Winners! Each of these team members has shown outstanding performance in their areas of business within #SyneosHealth and we are proud to share their accomplishments. Thank you for your commitment and dedication to success! #WorkHereMattersEverywhere
Congratulations to the 2022 Year End Award Winners! Each of these team members has shown outstanding performance in their areas of business within #SyneosHealth and we are proud to share their accomplishments. Thank you for your commitment and dedication to success! #WorkHereMattersEverywhere
Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced the appointment of Michelle Keefe as CEO and a member of the Company’s Board of Directors. Keefe, currently President, Medical Affairs and Commercial Solutions, succeeds Alistair Macdonald, who will retire after 20 years at Syneos Health. Macdonald will remain an advisor to Syneos Health through March 2023. Keefe brings more than 30 years of life sciences industry experience to the role. Since joining Syneos Health in 2017, her leadership has driven the ongoing transformation of the Company’s Commercial business, including its second straight year of double-digit growth. Her successes across the product development continuum include launching Kinetic™, Syneos Health’s modern customer engagement capability, building integrated solutions such as Full-Service Commercial and Medical Affairs, and collaborating to drive growth in Syneos One, the Company’s unique end-to-end offering. [Full story available at https://bit.ly/shceomkgd]
We're proud to announce that Syneos Health has been named to Fortune Magazine’s “World’s Most Admired Companies” list again! We share this recognition with our employees, customers and communities who continue to work tirelessly to bring new and innovative medicines to patients worldwide. #WorkHereMattersEverywhere
